Wealth Enhancement Advisory Services
FMED icon

Wealth Enhancement Advisory Services’s Fidelity Disruptive Medicine ETF FMED Stock Holding History

Wealth Enhancement Advisory Services’s Portfolio FMED Stock Details FMED Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-386,395
Closed -$9.53M – 4175
2026
Q1 		$9.53M Sell
386,395
-328,596
-46% -$8.55M 0.02% 598
2025
Q4 		$19.7M Buy
714,991
+31,629
+5% +$852K 0.03% 485
2025
Q3 		$17.5M Sell
683,362
-5,388
-0.8% -$130K 0.03% 486
2025
Q2 		$16.5M Buy
688,750
+76,538
+13% +$1.79M 0.03% 478
2025
Q1 		$14.5M Buy
612,212
+28,597
+5% +$722K 0.03% 492
2024
Q4 		$14.4M Buy
583,615
+43,788
+8% +$1.13M 0.03% 462
2024
Q3 		$14.2M Buy
539,827
+19,240
+4% +$486K 0.03% 429
2024
Q2 		$12.5M Buy
520,587
+23,730
+5% +$573K 0.03% 425
2024
Q1 		$12.7M Buy
496,857
+29,339
+6% +$725K 0.03% 410
2023
Q4 		$11.3M Buy
467,518
+1,532
+0.3% +$33.2K 0.03% 401
2023
Q3 		$10.3M Buy
+465,986
New +$11.2M 0.03% 400

Other funds holding FMED

FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
PA
Parallel Advisors San Francisco, California $6.56B AUM 32.24% 1-Year Est. Return
CPBTD
Central Pacific Bank - Trust Division Honolulu, Hawaii $984M AUM 34.19% 1-Year Est. Return
GJIA
Glass Jacobson Investment Advisors Owings Mills, Maryland $321M AUM 20.69% 1-Year Est. Return

Wealth Enhancement Advisory Services's FMED Position: Q2 2026 in Review

Wealth Enhancement Advisory Services sold out of Fidelity Disruptive Medicine ETF (FMED) in Q2 2026, closing a stake of 386,395 shares — an estimated $9.53M sold.

Wealth Enhancement Advisory Services first reported a position in FMED in Q3 2023 and held it in 11 quarters. The position peaked at $19.7M in Q4 2025. 4 funds tracked by Wall St. Rank hold FMED as of Q2 2026.

  • Wealth Enhancement Advisory Services reported no remaining Fidelity Disruptive Medicine ETF position as of Q2 2026 after selling out during the quarter.
  • Wealth Enhancement Advisory Services sold 386,395 Fidelity Disruptive Medicine ETF shares in Q2 2026, an estimated $9.53M.
  • Wealth Enhancement Advisory Services first reported a position in Fidelity Disruptive Medicine ETF in Q3 2023 and held it in 11 quarters.
  • Wealth Enhancement Advisory Services's Fidelity Disruptive Medicine ETF position peaked at $19.7M in Q4 2025.
  • 4 funds tracked by Wall St. Rank held Fidelity Disruptive Medicine ETF as of Q2 2026.

Based on Wealth Enhancement Advisory Services's 13F filing for Q2 2026, filed 15 Jul 2026.